We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Capsule Endoscopy in Obscure GI Bleeding

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00203619
Recruitment Status : Completed
First Posted : September 20, 2005
Last Update Posted : December 5, 2017
Sponsor:
Collaborators:
Alberta Heritage Foundation for Medical Research
Calgary Health Region
Information provided by (Responsible Party):
Dr. Robert Hilsden, University of Calgary

Brief Summary:
The purpose of this study is to conduct a cost-effectiveness analysis of wireless capsule endoscopy in the investigation of patients with overt obscure gastrointestinal bleeding. To inform this analysis, a randomized controlled trial of capsule endoscopy compared with standard care will be conducted

Condition or disease Intervention/treatment
Obscure Gastrointestinal Bleeding Device: Wireless capsule endoscopy Other: standard care

Detailed Description:
The purpose of this study is to conduct a cost-effectiveness analysis of wireless capsule endoscopy in the investigation of patients with overt obscure gastrointestinal bleeding. To inform this analysis, a randomized controlled trial of capsule endoscopy compared with standard care will be conducted. Patients randomized 1:1.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: An Economic Evaluation of Capsule Endoscopy for Obscure Gastrointestinal Bleeding
Study Start Date : May 2005
Primary Completion Date : September 2015
Study Completion Date : September 2016

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: 1
Wireless capsule endoscopy
Device: Wireless capsule endoscopy
wire less capsule endoscopy
Active Comparator: 2
Standard care
Other: standard care
standard diagnostic evaluation as decided by treating physician



Primary Outcome Measures :
  1. sf36 [ Time Frame: 48 weeks ]
  2. giqli [ Time Frame: 48 weeks ]
  3. eq50 [ Time Frame: 48 weeks ]
  4. diagnostic yield [ Time Frame: 48 weeks ]

Secondary Outcome Measures :
  1. transfusions [ Time Frame: 48 weeks ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Age 18 or older
  2. Obscure overt GI bleeding
  3. No cause for bleeding found on Gastroscopy and colonoscopy within 1 week of bleeding

Exclusion Criteria:

  1. Known or suspected swallowing disorders
  2. Known or suspected small bowel obstruction
  3. Multiple comorbidities precluding surgery
  4. Patients with implantable electromagnetic devices
  5. Pregnant women

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00203619


Locations
Canada, Alberta
University of Calgary
Calgary, Alberta, Canada, T2N4N1
Sponsors and Collaborators
University of Calgary
Alberta Heritage Foundation for Medical Research
Calgary Health Region
Investigators
Principal Investigator: Robert J Hilsden, MD PhD University of Calgary

Responsible Party: Dr. Robert Hilsden, Associate Professor, Department of Medicine & Research Director, Colon Cancer Screening Centre, University of Calgary
ClinicalTrials.gov Identifier: NCT00203619     History of Changes
Other Study ID Numbers: 1
First Posted: September 20, 2005    Key Record Dates
Last Update Posted: December 5, 2017
Last Verified: December 2017

Additional relevant MeSH terms:
Hemorrhage
Gastrointestinal Hemorrhage
Pathologic Processes
Gastrointestinal Diseases
Digestive System Diseases